Iran Press/ Iran News: In an interview with Iran Press News Agency at the sideline of the unveiling ceremony of COVID-19 therapy trials, including Favipiravir, Remdesivir in Actover company, Head of the headquarters for the management of operations against coronavirus, Alireza Zali said that other domestically built COVID-19 protective apperatus include ventilators, respiratory aids, oxygen generators, as well as mechanical ventilation aids, and they are scheduled to be exported.
Zali further noted that due to high consumption, some of the anti-coronavirus medicines will be exported after meeting the country's needs.
Zali said: "According to the latest global assessment, over 74 coronavirus medicines have been dispensed since its unset and may even be more diverse, some of these 74 medicines are of higher consumption.
"Fortunately, most of them are produced in Iran despite their complex technology and relatively difficult production," Alireza Zali noted.
"To cure the coronavirus, the protocols of therapy trials have not yet lead to the desired results, hence many clinical trials are underway in Iran and the world to find medicines with the highest efficacy, but still, there is no medicine to contain the virus definitely," Alireza Zali underlined.
"Containment of COVID-19 has been tried in many ways such as using various medicines. Fortunately, in Iran, with domestic manufacturers' cooperation, all the medicines used in the world to contain the novel virus were prepared for the people, despite the US imposed sanctions," Head of the headquarters for the management of operations against coronavirus in Tehran Alireza Zali told Iran Press.
207/205
Read more:
Iran, to be become COVID-19 vaccine regional hub
Sputnik V, a safe vaccine, a good immunization
